Riverview Capital Advisers, LLC Laboratory Corp Of America Holdings Transaction History

Riverview Capital Advisers, LLC

  • $291 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$209.01 - $232.56 $17,556 - $19,535
-84 Reduced 1.04%
8,000 $1.75 Million
Q2 2023

Aug 04, 2023
BUY
$211.93 - $241.33 $17,802 - $20,271
84 Added 1.05%
8,084 $1.95 Million
Q4 2021

Feb 07, 2023
BUY
$271.6 - $314.21 $2.17 Million - $2.51 Million
8,000 New
8,000 $2.51 Billion

Others Institutions Holding LH

# of Institutions
130
Shares Held
2.5M
Call Options Held
0
Put Options Held
0
View Full List

About LABORATORY CORP OF AMERICA HOLDINGS

LH Quotes by TradingView
  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.1B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Riverview Capital Advisers, LLC Portfolio

Follow Riverview Capital Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Riverview Capital Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Riverview Capital Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email